The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Client Survey Report - 2024
-
What did we learn from you in 2024?In October, PAAB sent out our Client Survey to better understand your experience with us — what’s working, what’s not, and where we can grow together.
This year’s survey offered deeper insights into awareness of recent Code and guidance updates, and helped us identify how we can better support your PAAB experience moving forward.
Thank you to everyone who participated. Your feedback is already driving improvements across training, review practices, and communication.
Check out the full Customer Insights Report
